期刊文献+

低危非肌层浸润性膀胱癌术后即刻膀胱灌注与维持膀胱灌注的疗效对比 被引量:2

Efficacy comparison of immediate bladder irrigation versus maintenance bladder irrigation after surgery for low-risk non-muscle-invasive bladder cancer
下载PDF
导出
摘要 目的分析低危非肌层浸润性膀胱癌(NMIBC)术后患者分别采用即刻膀胱灌注与维持膀胱灌注吡柔比星(THP)的方式进行治疗的效果及不良反应发生情况。方法60例低危NMIBC患者,随机分为观察组和对照组,每组30例。两组患者均接受经尿道膀胱肿瘤电切术(TURBT),观察组患者术后采用即刻灌注,对照组患者术后采用维持灌注。随访至术后1年,比较两组患者血清血管内皮生长因子(VEGF)、成纤维细胞生长因子(FGF)、可溶性细胞间粘附分子-1(sICAM-1)水平及术后复发率、不良反应发生情况。结果术后1年,观察组患者血清VEGF、FGF、sICAM-1水平分别为(32.23±4.12)ng/ml、(14.68±1.34)pg/L、(97.12±8.35)ng/L,对照组患者分别为(31.11±5.42)ng/ml、(13.67±2.46)pg/L、(95.33±12.42)ng/L,比较差异无统计学意义(P>0.05)。观察组患者复发率为13.33%,对照组为10.00%,比较差异无统计学意义(P>0.05)。观察组患者不良反应发生率为6.67%,显著低于对照组的26.67%,差异有统计学意义(P<0.05)。结论低危NMIBC术后即刻膀胱灌注的肿瘤标注物水平、肿瘤复发率与维持膀胱灌注无显著差异,同时不良反应较少,可以减少患者治疗的痛苦和经济负担,具有较高的临床应用价值。 Objective To analyze the effect and occurrence of adverse reactions of treatment with immediate bladder irrigation versus maintenance bladder irrigation with piroplatin(THP)in patients with lowrisk non-muscle invasive bladder cancer(NMIBC)after surgery.Methods A total of 60 patients with low-risk NMIBC were randomly divided into an observation group and a control group,with 30 patients in each group.Patients in both groups underwent transurethral resection of bladder tumor(TURBT),with immediate irrigation in the observation group and maintenance irrigation in the control group.The patients were followed up to 1 year after surgery,the serum levels of vascular endothelial growth factor(VEGF),fibroblast growth factor(FGF),soluble intercellular adhesion molecule-1(sICAM-1),postoperative recurrence rate,and occurrence of adverse reactions were compared between the two groups.Results At 1 year after surgery,the serum levels of VEGF,FGF,and sICAM-1 were(32.23±4.12)ng/ml,(14.68±1.34)pg/L,and(97.12±8.35)ng/L in the observation group,and(31.11±5.42)ng/ml,(13.67±2.46)pg/L,and(95.33±12.42)ng/L in the control group.The differences were not statistically significant between the two groups(P>0.05).The recurrence rate was 13.33%in the observation group and 10.00%in the control group,and the difference was not statistically significant(P>0.05).The incidence of adverse reactions was 6.67%in the observation group,which was significantly lower than 26.67%in the control group,and the difference was statistically significant(P<0.05).Conclusion The level of tumor markers and tumor recurrence rate of immediate bladder irrigation in low-risk NMIBC are not significantly different from that of maintenance bladder irrigation,while the adverse reactions are less,which can reduce the pain and economic burden of patients and have high clinical application value.
作者 杨明州 万刚 姜兴金 魏伟 王海波 刘建光 杨进益 YANG Ming-zhou;WAN Gang;JIANG Xing-jin(Dalian Urology Department,Dalian Friendship Hospital,Dalian 116001,China)
出处 《中国实用医药》 2023年第3期55-58,共4页 China Practical Medicine
关键词 低危非肌层浸润性膀胱癌 吡柔比星 即刻膀胱灌注 复发率 不良反应 Low-risk non-muscle-invasive bladder cancer Pirarubicin Immediate bladder irrigation Recurrence rate Adverse reactions
  • 相关文献

参考文献10

二级参考文献63

  • 1陈智伟,廖美琳.RECIST标准在肿瘤治疗疗效评价中的应用[J].中国肿瘤,2004,13(10):616-618. 被引量:177
  • 2朱捷,徐阿祥,洪宝发,叶林阳,张磊,王晓雄.两种膀胱灌注疗法影响浅表性膀胱癌术后患者生活质量和复发等预后因素的比较[J].中国临床康复,2005,9(22):152-154. 被引量:2
  • 3邱志磊,牛海涛,孙光.2005年欧洲泌尿外科会议膀胱癌诊断治疗纲要[J].临床泌尿外科杂志,2006,21(4):318-320. 被引量:38
  • 4鄢阳,郑军华,许云飞,张海民,黄建华,彭波,高其若,黄国华,巢月根,孔宪国.膀胱癌组织中MMP-2、MMP-9、VEGF和RECK基因的表达及临床意义[J].第二军医大学学报,2007,28(10):1075-1078. 被引量:11
  • 5Pacheco-Figueiredo L,Antunes L,Bento MJ,et al.Evaluation of the frequency of and survival from second primary cancers in North Portugal:apopulation-based study[J].Eur J Cancer Prev,2013,22(6):599-606.
  • 6Allchorne P,Lamb BW,Kinsella J,et al.Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure[J].Urol Nurs,2014,34(2):95-99.
  • 7Milla P,Fiorito C,Soria F,et al.Intravesical thermo-chemotherapy based on conductive heat:a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients[J].Cancer Chemother Pharmacol,2014,73(3):503-509.
  • 8Hirata T,Watanabe M,Kaku H,et al.REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer[J].Int J Oncol,2012,41(2):559-564.
  • 9Kaba M,Pirincci N,Benli E,et al.Dickkopf-1levels in Turkish patients with bladder cancer and its association with clinicopathological features[J].Asian Pac J Cancer Prev,2014,15(1):381-384.
  • 10Pili R,Qin R,Flynn PJ,et al.A phaseⅡsafety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer[J].Clin Genitourin Cancer,2013,11(4):477-483.

共引文献149

同被引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部